BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Li CW, Yang CJ, Sun HY, Tsai MS, Lin SP, Lin TY, Cheng CY, Lee YC, Huang YS, Liu CE, Lee YT, Tang HJ, Wang NC, Cheng SH, Ko WC, Hung CC; Taiwan HIV Study Group. Changing seroprevalence of hepatitis C virus infection among HIV-positive patients in Taiwan. PLoS One 2018;13:e0194149. [PMID: 29547628 DOI: 10.1371/journal.pone.0194149] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
Number Citing Articles
1 Sun HY, Uemura H, Wong NS, Chan DP, Wong BC, Lin PH, Su LH, Hung CC, Oka S, Chang SY, Lee SS. Molecular epidemiology of acute HCV infection in HIV-positive patients from Hong Kong, Taipei, Tokyo. Liver Int 2019;39:1044-51. [PMID: 30770636 DOI: 10.1111/liv.14073] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
2 Su PY, Chen YY, Yen HH, Huang SP, Liu IL, Zeng YH, Hsu YC, Siao FY. Strategy for the Micro-Elimination of Hepatitis C among Patients with Diabetes Mellitus-A Hospital-Based Experience. J Clin Med 2021;10:2509. [PMID: 34204064 DOI: 10.3390/jcm10112509] [Reference Citation Analysis]
3 Wu GH, Yang WW, Liu CL, Pwu RF, Chien RN, Lee PC, Chen SC, Chen DS, Lu SN. The epidemiological profile of chronic hepatitis C with advanced hepatic fibrosis regarding virus genotype in Taiwan: A nationwide study. J Formos Med Assoc 2021;120:1444-51. [PMID: 33516585 DOI: 10.1016/j.jfma.2021.01.005] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Pappoe F, Hagan CKO, Obiri-Yeboah D, Nsiah P. Sero-prevalence of hepatitis B and C viral infections in Ghanaian HIV positive cohort: a consideration for their health care. BMC Infect Dis 2019;19:380. [PMID: 31053100 DOI: 10.1186/s12879-019-4027-y] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
5 Yen HH, Su PY, Liu II, Zeng YH, Huang SP, Hsu YC, Hsu PK, Chen YY. Retrieval of lost patients in the system for hepatitis C microelimination: a single-center retrospective study. BMC Gastroenterol 2021;21:209. [PMID: 33964873 DOI: 10.1186/s12876-021-01792-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
6 Lin KY, Sun HY, Lee TF, Chuang YC, Wu UI, Liu WC, Chang SY, Chen YJ, Hung CC, Chang SC. High prevalence of sexually transmitted coinfections among at-risk people living with HIV. J Formos Med Assoc 2021;120:1876-83. [PMID: 33341349 DOI: 10.1016/j.jfma.2020.12.008] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
7 Chien RN, Lu SN, Pwu RF, Wu GH, Yang WW, Liu CL. Taiwan accelerates its efforts to eliminate hepatitis C. Glob Health Med 2021;3:293-300. [PMID: 34782872 DOI: 10.35772/ghm.2021.01064] [Reference Citation Analysis]
8 Su PS, Su CW, Wu SH, Wei TH, Chu CJ, Lin CC, Lee SD, Wang YJ, Lee FY, Huang YH, Hou MC. Well tolerability and highly effective treatment response for hepatitis C virus-human immunodeficiency virus-coinfected patients treated by all-oral direct-acting antivirals. J Chin Med Assoc 2021;84:465-71. [PMID: 33871393 DOI: 10.1097/JCMA.0000000000000528] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Ho SY, Su LH, Sun HY, Huang YS, Chuang YC, Huang MH, Liu WC, Su YC, Lin PH, Chang SY, Hung CC. Trends of recent hepatitis C virus infection among HIV-positive men who have sex with men in Taiwan, 2011-2018.EClinicalMedicine. 2020;24:100441. [PMID: 32637905 DOI: 10.1016/j.eclinm.2020.100441] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]